Pierre Delanaye , Martin Flamant , Emmanuelle Vidal-Petiot , Jonas Björk , Ulf Nyman , Anders Grubb , Stephan J.L. Bakker , Martin H. de Borst , Marco van Londen , Laurence Derain-Dubourg , Andrew D. Rule , Björn O. Eriksen , Toralf Melsom , Per-Ola Sundin , Natalie Ebert , Elke Schaeffner , Magnus Hansson , Karin Littmann , Anders Larsson , Thomas Stehlé , Hans Pottel
{"title":"Discordant Results Between Creatinine- and Cystatin C-based Equations for Estimating GFR","authors":"Pierre Delanaye , Martin Flamant , Emmanuelle Vidal-Petiot , Jonas Björk , Ulf Nyman , Anders Grubb , Stephan J.L. Bakker , Martin H. de Borst , Marco van Londen , Laurence Derain-Dubourg , Andrew D. Rule , Björn O. Eriksen , Toralf Melsom , Per-Ola Sundin , Natalie Ebert , Elke Schaeffner , Magnus Hansson , Karin Littmann , Anders Larsson , Thomas Stehlé , Hans Pottel","doi":"10.1016/j.ekir.2025.01.030","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Discordant results between cystatin C and creatinine in estimating glomerular filtration rate (GFR) are an important medical issue. However, the equation that should be used when GFR estimates are discordant remains unclear.</div></div><div><h3>Methods</h3><div>This cross-sectional analysis included 15,485 participants with GFR measured by the clearance of an exogenous marker, serum creatinine, and cystatin C. We studied the proportion of discordant results defined as an absolute (> 15 ml/min per 1.73 m<sup>2</sup>) or relative (> 20%) difference between creatinine-based estimated GFR (eGFR, eGFR<sub>crea</sub>) and cystatin C–based eGFR (eGFR<sub>cys</sub>) using different equations (Chronic Kidney Disease Epidemiology Collaboration [CKD-EPI], European Kidney Function Consortium [EKFC], and reexpressed Lund-Malmö [r-LMR]). We also researched for the best estimating equations to be used in subjects with concordant or discordant results to estimate measured GFR (mGFR).</div></div><div><h3>Results</h3><div>In the total cohort, the proportion of subjects with discordant results (absolute or relative) was larger for CKD-EPI (35.1 and 40.6%) than for EKFC (21.9 and 31.7%) or r-LMR (22.8 and 32.8%) equations. Among discrepant results, the proportion of eGFR<sub>cys</sub> < eGFR<sub>crea</sub> was significantly higher than the proportion of eGFR<sub>crea</sub> < eGFR<sub>cys</sub> for the CKD-EPI equations, whereas the occurrence of discrepancy was similar in the 2 discrepant groups for EKFC or r-LMR. For the EKFC and r-LMR equations, but not for the CKD-EPI, the equation combining creatinine and cystatin C was consistently the closest to the mGFR in the discrepant groups.</div></div><div><h3>Conclusion</h3><div>Based on the lower discrepancy proportion, better balance between eGFR<sub>crea</sub> and eGFR<sub>cys</sub>, and better concordance with mGFR, the EKFC, and r-LMR equations should be preferred over the CKD-EPI to estimate GFR.</div></div>","PeriodicalId":17761,"journal":{"name":"Kidney International Reports","volume":"10 4","pages":"Pages 1248-1259"},"PeriodicalIF":5.7000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Kidney International Reports","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2468024925000555","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction
Discordant results between cystatin C and creatinine in estimating glomerular filtration rate (GFR) are an important medical issue. However, the equation that should be used when GFR estimates are discordant remains unclear.
Methods
This cross-sectional analysis included 15,485 participants with GFR measured by the clearance of an exogenous marker, serum creatinine, and cystatin C. We studied the proportion of discordant results defined as an absolute (> 15 ml/min per 1.73 m2) or relative (> 20%) difference between creatinine-based estimated GFR (eGFR, eGFRcrea) and cystatin C–based eGFR (eGFRcys) using different equations (Chronic Kidney Disease Epidemiology Collaboration [CKD-EPI], European Kidney Function Consortium [EKFC], and reexpressed Lund-Malmö [r-LMR]). We also researched for the best estimating equations to be used in subjects with concordant or discordant results to estimate measured GFR (mGFR).
Results
In the total cohort, the proportion of subjects with discordant results (absolute or relative) was larger for CKD-EPI (35.1 and 40.6%) than for EKFC (21.9 and 31.7%) or r-LMR (22.8 and 32.8%) equations. Among discrepant results, the proportion of eGFRcys < eGFRcrea was significantly higher than the proportion of eGFRcrea < eGFRcys for the CKD-EPI equations, whereas the occurrence of discrepancy was similar in the 2 discrepant groups for EKFC or r-LMR. For the EKFC and r-LMR equations, but not for the CKD-EPI, the equation combining creatinine and cystatin C was consistently the closest to the mGFR in the discrepant groups.
Conclusion
Based on the lower discrepancy proportion, better balance between eGFRcrea and eGFRcys, and better concordance with mGFR, the EKFC, and r-LMR equations should be preferred over the CKD-EPI to estimate GFR.
期刊介绍:
Kidney International Reports, an official journal of the International Society of Nephrology, is a peer-reviewed, open access journal devoted to the publication of leading research and developments related to kidney disease. With the primary aim of contributing to improved care of patients with kidney disease, the journal will publish original clinical and select translational articles and educational content related to the pathogenesis, evaluation and management of acute and chronic kidney disease, end stage renal disease (including transplantation), acid-base, fluid and electrolyte disturbances and hypertension. Of particular interest are submissions related to clinical trials, epidemiology, systematic reviews (including meta-analyses) and outcomes research. The journal will also provide a platform for wider dissemination of national and regional guidelines as well as consensus meeting reports.